Magenta Medical — an Israeli company developing what it bills as “the world’s smallest heart pump” — closed a $55 million financing round on Wednesday.
The round was led by OrbiMed, with participation from New Enterprise Associates, Pitango and Alive Israel HealthTech Fund. Magenta did not disclose how much the company has raised to date.
The new funding will be used primarily to help the medtech company attain FDA approval for its flagship product — a percutaneous left ventricular assist device called Elevate.
Comments are closed.